Carcinogenesis, Vol. 20, No. 10, 1927-1931,
October 1999
© 1999 Oxford University Press
Molecular Epidemiology and Cancer Prevention |
Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer
Maxillofacial Surgery, Graduate School, Tokyo Medical and Dental University, 5-45 Yushima 1-chome, Bunkyo-ku, Tokyo 113-8549 and
1 Department of Clinical Pathology, Saitama Cancer Center, 818 Komuro, Ina-machi, Saitama 362-0806, Japan
An individual difference in the susceptibility to chemical carcinogens is one of the most important factors in the estimate of risk of human cancer. Recently, it has been reported that genetic risk for tobacco-related cancers is associated with polymorphisms of the CYP1A1 and GSTM1 genes in terms of genotype frequencies and cigarette smoking dose. In this study, we investigated the inter-individual difference in genetically determined susceptibility to oral squamous cell carcinoma (SCC) in relation to cigarette smoking dose in a Japanese population. DNA samples were obtained from both patients and controls. We identified individuals at high risk genetically for oral SCC in terms of polymorphisms of the CYP1A1 and GSTM1 genes. This study then compared the estimated total number of cigarettes smoked by patients with those smoked by controls. In this case–control study, we estimated the odds ratios of susceptible to non-susceptible individuals. CYP1A1 genotype C and GSTM1 deficiency were frequently found among oral SCC patients. Patients with genotype C and GSTM1 deficiency contracted carcinoma after fewer cigarettes than those with other genotypes. Individuals with these two genotypes were at remarkably high risk at a low dose level of cigarette smoking. Individual differences in polymorphisms of the CYP1A1 and GSTM1 genes is one important factor in the estimate of risk of oral SCC at a low dose level of cigarette smoking.
Abbreviations: SCC, squamous cell carcinoma.
2 To whom correspondence should be addressed Email: ta-sato.os1{at}dent.tmd.ac.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  X. Chen and K. J. Woodcroft Polymorphisms in metabolic genes CYP1A1 and GSTM1 and changes in maternal smoking during pregnancy Nicotine Tob Res, March 1, 2009; 11(3): 225 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Anantharaman, P. M. Chaubal, S. Kannan, R. A. Bhisey, and M. B. Mahimkar Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator Carcinogenesis, July 1, 2007; 28(7): 1455 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Masson, L. Sharp, S. C. Cotton, and J. Little Cytochrome P-450 1A1 Gene Polymorphisms and Risk of Breast Cancer: A HuGE Review Am. J. Epidemiol., May 15, 2005; 161(10): 901 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z Ye, H Song, and Y Guo Glutathione S-transferase M1, T1 status and the risk of head and neck cancer: a meta-analysis J. Med. Genet., May 1, 2004; 41(5): 360 - 365. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Szekely, E. Remenar, M. Kasler, and S. Gundy Does the bleomycin sensitivity assay express cancer phenotype? Mutagenesis, January 1, 2003; 18(1): 59 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Geisler and A. F. Olshan GSTM1, GSTT1, and the Risk of Squamous Cell Carcinoma of the Head and Neck: A Mini-HuGE Review Am. J. Epidemiol., July 15, 2001; 154(2): 95 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Schwarz, P. Kisselev, I. Cascorbi, W.-H. Schunck, and I. Roots Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants Carcinogenesis, March 1, 2001; 22(3): 453 - 459. [Abstract] [Full Text] [PDF]
|
|